Medplus Health Services Limited IPO (Medplus Health IPO)
.png)
Medplus Health Services Limited opened their subscription on 13th December 2021 and is available for bidding till 15th December 2021.
Medplus Health Services are promoted by Gangadi Madhukar Reddy, Lone Furrow Investments Pvt Ltd, and Agilemed Investments Pvt Ltd.
| IPO Opening Date | Dec 13, 2021 |
| IPO Closing Date | Dec 15, 2021 |
| Face Value | ₹2 per equity share |
| IPO Price | ₹780 to ₹796 per equity share |
| Market Lot | 18 Shares |
| Min Order Quantity | 18 Shares |
| Listing At | BSE, NSE |
| Issue Size | [.] Eq Shares of ₹2 (aggregating up to ₹1,398.30 Cr) |
| Fresh Issue | [.] Eq Shares of ₹2 (aggregating up to ₹600.00 Cr) |
| Offer for Sale | [.] Eq Shares of ₹2 (aggregating up to ₹798.30 Cr) |
Efficiently Launch your finance learning journey
Explore the full course and see how our demo class can help you master new skills. Choose your path below!
Monday - Friday (9am - 6pm)
Customer Support:
email: masterclass@capitalvia.com
phone: 0731-3112886
Human Resource:
email: hr@capitalvia.com
phone: 0731-3541392
Registered Office:
1st Floor Spring Board, Kagalwala House, Plot No. 175, Behind Metro House, CST Road, Kalina, Bandra Kurla Complex, Santacruz East, Mumbai-400098, Maharashtra, India.
Corporate Office:
903, B-1, 9th Floor, NRK Business Park, Scheme No. 54, P.U.-4,Vijay Nagar Square, Indore-452010, Madhya Pradesh, India
Disclaimer: Content is for information and educational purposes only and does not constitute an offer or solicitation for the purchase or sale of any financial instrument. Any reference to any security(s) are for illustration only and are not recommendatory. Although the best efforts have been made to ensure all information is accurate and up to date, occasionally unintended errors may occur. We have a 'NO REFUND' policy. NOTE: Investment in securities market is subject to market risks. Read all the related documents carefully before investing.
Copyright©️ 2025 CapitalVia Global Research Limited. CapitalVia®️ is a registered trademark of CapitalVia Global Research Limited.